Edesa Biotech Research, Inc.
Registration:
10
of
11
(2023-10-01
to
2024-03-01)
Grant, Contribution or Other Financial Benefit
- Seeking funding to allow for increased research and development and other expenditures into two clinical-stage antibodies to treat acute respiratory distress syndrome (the primary cause of death from COVID-19) from the Industrial Research Assistance Program and the Strategic Innovation Fund.